Warning letter
Hawaii Pharm LLC: warning letter of Apr 24, 2020
FDA warning letter 599389 · Division of Human and Animal Food Operations West V
Key facts
| Reference number | 599389 |
|---|---|
| Company | Hawaii Pharm LLC |
| Subject | CGMP/Dietary Supplement/Adulterated/Misbranded |
| Issue date | Apr 24, 2020 |
| Posted date | May 5, 2020 |
| Issuing office | Division of Human and Animal Food Operations West V |
| Product type | Food/Cosmetics |
| CFR sections cited | 101.4(h)(1), 11, 101, 101.36, 111, 101.4(g), 111.70(b), 111.70(b)(1), 111.70(e), 111.83(a), 111.83(b)(3), 111.205(a) and 7 more |
| Inspection city | Honolulu |
| Inspection ZIP | 96817 |
| Inspection start date | Oct 30, 2019 |
| Letter on fda.gov | fda.gov |
At a glance
- 10–99 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: